Previous Close | 14.41 |
Open | 14.51 |
Bid | 14.20 x 1000 |
Ask | 14.22 x 1000 |
Day's Range | 14.11 - 14.79 |
52 Week Range | 10.60 - 24.96 |
Volume | |
Avg. Volume | 759,801 |
Market Cap | 2.27B |
Beta (5Y Monthly) | 1.46 |
PE Ratio (TTM) | 118.42 |
EPS (TTM) | 0.12 |
Earnings Date | Nov 06, 2023 - Nov 10, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 19.14 |
Subscribe to Yahoo Finance Plus to view Fair Value for CERT
Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelinesPRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has successfully supported 300 completed submissions to regulatory agencies worldwide. Submissions include those to initiate clinical trials, such as Investigational New Drug (IND) or Clinical Trial Application (CTA) and marketing applications, such as New Drug Appli
Certara, Inc. ( NASDAQ:CERT ), is not the largest company out there, but it received a lot of attention from a...
On September 11, 2023, Leif Pedersen, President and Chief Commercial Officer of Certara Inc (NASDAQ:CERT), sold 51,224 shares of the company.